The German Constitutional Courtroom issued a landmark choice with implications for a lot of corporations doing enterprise in Europe on July 9, 2021. For many years, the European Fee and EU member states strived to create a pan-European Unified Patent Courtroom (UPC). After overcoming many hurdles, any wise commentator will likely be cautious in making statements about the way forward for the UPC. That mentioned, for the primary time in years it now seems that the pan-European patent litigation system could lastly come into being. That is significantly related for corporations from the life sciences sector that are inclined to implement their blockbuster patents in parallel proceedings in essentially the most related jurisdictions. The brand new system and the provision of pan-European injunctions implies that claimants will have the ability to transfer from 5 parallel instances to 1. Nevertheless, the brand new system additionally comes with disadvantages similar to pan-European invalidation proceedings. No person can predict the standard of judgments issued by the longer term court docket. For homeowners of European patents who’re involved about dropping their IP rights, now’s the time to establish the crown jewels and to make an knowledgeable choice about opting out.